Vanishing Adrenal Glands: Bilateral Adrenal Hemorrhage With Adrenal Insufficiency in COVID-19 Infection.

adrenal hemorrhage adrenal insufficiency antiphospholipid syndrome coronavirus disease 2019 covid-19 infection mineralocorticoid

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jun 2023
Historique:
accepted: 30 06 2023
medline: 1 8 2023
pubmed: 1 8 2023
entrez: 1 8 2023
Statut: epublish

Résumé

Coronavirus disease 2019 (COVID-19) has been associated with thrombotic and endocrine complications, including adrenal insufficiency in the setting of adrenal hemorrhage. We present a patient diagnosed with antiphospholipid syndrome (APLS) in the setting of COVID-19 infection resulting in bilateral adrenal hemorrhage, subsequently leading to adrenal insufficiency. Acute adrenal hemorrhage is an underrecognized cause of decompensation, multisystem failure, and death in severe illness. Reports of adrenal insufficiency in the setting of COVID-19 infection revealed microscopic infarction, which can increase the risk of hemorrhage. Other mechanisms include severe hyperinflammatory response and cytokine storm leading to endothelial dysfunction, vascular injury, adrenal parenchymal damage, and hemorrhage. COVID-19 infection can be associated with coagulopathy and thromboembolic events and can lead to adrenal hemorrhage. Adrenal insufficiency is life-threatening and needs to be recognized promptly. There can be a latent phase between hemorrhagic events and adrenal failure; hence, close monitoring and timely intervention are important.

Identifiants

pubmed: 37525808
doi: 10.7759/cureus.41210
pmc: PMC10387330
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e41210

Informations de copyright

Copyright © 2023, Majety et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Clin Endocrinol Metab. 2020 Dec 1;105(12):
pubmed: 32738040
BJR Case Rep. 2020 Jun 04;6(3):20200075
pubmed: 32922854
Radiol Case Rep. 2021 Jun;16(6):1438-1442
pubmed: 33815638
Ann Intern Med. 1989 Feb 1;110(3):227-35
pubmed: 2643380
Nagoya J Med Sci. 2021 Nov;83(4):883-891
pubmed: 34916731
Clin Endocrinol (Oxf). 2023 Jun;98(6):766-778
pubmed: 36710422
AACE Clin Case Rep. 2019 Aug 15;5(6):e334-e339
pubmed: 31967065
J Pathol. 1976 Jun;119(2):65-89
pubmed: 932879
Rev Med Chil. 2021 Jul;149(7):1081-1084
pubmed: 34751311
N Engl J Med. 2020 Apr 23;382(17):e38
pubmed: 32268022
Endocr Connect. 2021 Sep 20;10(9):R229-R239
pubmed: 34424853
J Clin Endocrinol Metab. 2021 Jul 29;107(1):e394–e400
pubmed: 34324679
AACE Clin Case Rep. 2023 May-Jun;9(3):71-73
pubmed: 37206647
Eur Radiol. 2021 Feb;31(2):895-900
pubmed: 32852586
Am J Trop Med Hyg. 2020 Sep;103(3):1156-1157
pubmed: 32682452
J Clin Endocrinol Metab. 2013 Aug;98(8):3179-89
pubmed: 23783099

Auteurs

Priyanka Majety (P)

Endocrinology, Diabetes, and Metabolism, Virginia Commonwealth University, Richmond, USA.

Natanie Erlikh (N)

Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA.

Runhua Hou (R)

Endocrinology, Diabetes, and Metabolism, Massachusetts General Hospital, Harvard Medical School, Boston, USA.

Classifications MeSH